Loading...
Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs
OBJECTIVE: The objective of this study is to examine the risk of serious infections (SIs) associated with biological disease‐modifying antirheumatic drugs (bDMARDs) compared with conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs) in patients with rheumatoid arthritis (RA). METHO...
Na minha lista:
| Udgivet i: | ACR Open Rheumatol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6858027/ https://ncbi.nlm.nih.gov/pubmed/31777822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr2.11064 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|